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Letter to the Editor
Reply to the Editor:
We thank Dr Habib and colleagues for their
interest in this topic. The issue of whether
gender, size, or gender in combination with
size can explain the worse early mortality
after coronary artery bypass graft (CABG)
surgery has been an ongoing debate. There
still is no comprehensive evidence of what
aspects of gender contribute to this in-
creased early mortality risk; however, a
strong association to body size has been
previously described.1 It also has been
shown that the gender effect of worse early
outcome rates of death and low output syn-
drome remain despite adjustment for body
size, even when more detailed clinical data
are available.1 Size is important, but it is
not the only factor that distinguishes men
from women, and this certainly deserves
more research. A recent article by Koch
and coworkers2 used propensity analysis to
match women and men using 68 covari-
ates. As seen in this study, only 26% of
women from their entire cohort were
matched, which certainly limited the gen-
eralizability of the study findings for the
entire population of women undergoing
CABG surgery. Regardless, likely there are
factors other than size for women that lead
to worse early outcomes after CABG sur-
gery. There is some evidence to show that
off-pump coronary artery bypass surgery
might reduce adverse outcomes for wom-
en.3 Unfortunately, off-pump coronary ar-
tery bypass trials will always have a mi-
nority of women and thus not be powered
to understand the gender effect fully. Per-
haps studies understanding the differential
gender response to cardiopulmonary by-
pass and myocardial ischemia are required
to more fully understand why there is a
gender difference. Retrospective studies,
even with detailed clinical data, will never
be sufficient to conclusively identify the
cause behind this observation, and size
only explains part of the gender story. We
can all agree that it is time for the research
community to look beyond simple gender
differences and work in a concerted man-
ner to try and identify the biologic factors
that contribute to gender differences in
CABG surgery outcomes.
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Something to expect, diagnose, and
treat early
To the Editor:
We read with interest the article entitled
“Evolutional aspects of children and ado-
lescents with surgically corrected aortic co-
arctation: clinical, echocardiographic, and
magnetic resonance image analysis of 113
patients.”1 We learned that transverse aor-
tic arch hypoplasia should be corrected
concomitantly with coarctation.
Nothing about the chest radiograph or
cardiothoracic ratio was mentioned. In the
authors’ echocardiographic analysis, they
did not comment about the dimensions or
functions of the cardiac chamber, although
left ventricular hyperkinesia and increased
ventricular mass are found even in normo-
tensive patients long after successful coarc-
tation repair: increased ventricular mass
can provoke rhythm disturbances and
might cause an imbalance between muscle
and coronary vessel growth, with de-
creased oxygen reserve. Their series is a
select group, and not all patients undergo-
ing operations during this 26-year period
were included. Therefore, the study is sub-
ject to biases and is weak. The definition of
recoarctation is to be broadened to include
the systolic gradient between the right arm
and leg: measured with a sphygmomanom-
eter, Doppler echocardiography, magnetic
resonance angiography, and/or angiogra-
phy of the aortic isthmus and descending
aorta, systolic gradients and diameters
equal to or greater than 20 mm Hg at rest or
a combination of a right arm–leg pressure
gradient of more than 50 mm Hg after the
bicycle test and more than 40% reduction
in cross-sectional diameter of the aorta at
the anastomotic site compared with the
aorta at the level of the diaphragm.2
The recoarctation percentage after end-
to-end anastomosis (14%) is not correct: it
should be 12.53% rather than 14%. The
patch aortoplasty figure should be 7.69%
rather than 7%. However, this did not af-
fect the order of frequency. We do not
understand why the aortic ratio median be-
haved independently of age at coarctation
correction or why there was no significant
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difference between the median ratios of
each aortic level within all age groups. Was
there any correlation with the recoarctation
or with the hypertension?
Factors influencing the process of reco-
arctation are tubular hypoplasia of the aor-
tic arch, the surgical technique used, infec-
tive aortitis, complete resection of ductal
tissue, suture material, suture technique,
and width of the anastomosis. We do agree
with their conclusion that none of the non-
invasive methods used alone was sufficient
to diagnose aortic recoarctation in every
case, and they should be used as comple-
mentary methods. We would like to add
that magnetic resonance angiography is in-
dicated in all cases of suspected recoarcta-
tion. Currie and colleagues in 19854 state
that maximal catheter peak gradient equals
10.3 plus Doppler gradient.
What was the indication for surgical
intervention? They have seen cases associ-
ated with endocardititis or mesentric enter-
itis preoperatively or postoperatively. What
are the methods of spinal protection they
used to lessen the possibility of paraplegia,
and what is the upper limit in the aortic
clamp time?4
Sameh Elsayed, MD
Ahmed Kadri Abdulla
Abed Mowafii
Shaaban Abdul/Aziz Abulela
Mohammed Mounir Elsaeid Awadalla, MD
Department of Cardiothoracic Surgery
Mansoura University
Elgomhoria
Mansouria, Egypt
References
1. Smith Maia MMD, Cortês TM, Parga JR, de
Ávila LFR, Aiello VD, Barbero-Marcial M,
et al. Evolutional aspects of children and ad-
olescents with surgically corrected aortic co-
arctation: clinical, echocardiographic, and
magnetic resonance image analysis of 113
patients. J Thorac Cardiovasc Surg. 2004;
127:712-20.
2. Kappetein AP, Zwinderman AH, Bogers
AJJC, Rohmer J, Huysmans HA. More than
thirty-five years of coarctation repair: an un-
expected high relapse rate. J Thorac Cardio-
vasc Surg. 1994;107:87-95.
3. Brouwer RMHJ, Erasmus ME, Ebels T, Eij-
gelaar A. Influence of age on survival, late
hypertension, and recoarctation in elective
aortic coarctation repair including long-term
results after elective aortic coarctation repair
with a follow-up from 25 to 44 years. J Tho-
rac Cardiovasc Surg. 1994;108:525-31.
4. Currie PJ, Seward GB, Reed GS, Vliestra RE,
Brensahan DR, Brensahan JS, Jsmil HG, et al.
Continuous wave Doppler echocardiographic
assessment of severity of calcific aortic
stenosis: a simultaneous Doppler catheter
correlative study in 100 adult patients.
Circulation. 1985;71(6):1162-9.
doi:10.1016/j.jtcvs.2004.04.026
Reply to the Editor:
In response to Dr Elsayed’s questions, we
would like to clarify that 111 patients had
chest radiography postoperatively. In 57
(51.4%) patients the cardiothoracic ratio
was 0.53 or less, and in 54 patients it was
greater than 0.53. The left ventricular sil-
houette studied by the method was in-
creased in 55 (49.6%) patients. The systolic
ejection fraction (EF%) on echocardiogra-
phy was available postoperatively for 111
patients (mean, 79%  6%; median, 79%;
minimum, 45%; maximum, 92%). The left
ventricular mass was also available for 111
patients (mean, 104.32  28.24 g/m2; me-
dian, 100.00 g/m2; minimum, 50.00 g/m2;
maximum, 220.00 g/m2). The mean left
ventricular diastolic diameter available for
110 patients was 39.7  9.1 mm (median,
38.0 mm; minimum, 20.0 mm; maximum,
63.0 mm). We decided to not include these
variables because 78.8% of the patients had
associated cardiac lesions that could inter-
fere in the results. Furthermore, age and
sex also interfere in the left ventricular
mass, and the sample was not large enough
to include all these variables. In relation to
EF, we observed that in 24 patients with a
mean age at the time of the operation of
14.9  16.4 months (median, 6.8 months;
minimum, 25 days; maximum, 4.6 years),
EF before the operation (mean, 48% 
10%; median, 48%; minimum, 29%; max-
imum, 65%) had a favorable evolution
postoperatively (mean, 79%  5%; mini-
mum, 67%; maximum, 90%).
The aortic ratio median behaved the
same way independently of age at correc-
tion, meaning that it decreased progres-
sively up to the isthmus in each group. This
pattern of behavior was also observed in
normal adult patients1 studied by means of
computed tomography, but the relationship
was always greater than 1.
The recoarctation percentages relative
to surgical techniques were revised and are
correct.
About the surgical indications, 79% of
the patients were symptomatic. The main
symptoms were heart failure with or with-
out cyanosis in small babies (3 of them
were in shock), fatigue, ache in legs, and
headache in older children. In 92 (81.4%)
patients aortic coarctation was considered
severe (gradient at coarctation site 50
mm Hg), in 12 (10.6%) patients it was
moderate, and it could be not classified in 9
(8.0%) patients. Only 1 patient had infec-
tive endocarditis caused by Staphylococcus
aureus after the operation.
The method used for spinal protection
was to decrease the nasoesophageal tem-
perature down to 33°C by means of topical
pleural hypothermia. The upper limit of
aortic clamping was no more than 25 min-
utes.
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Assessing the value of neoadjuvant
chemoradiotherapy and pathologic
downstaging in the treatment of
non–small cell lung cancer
To the Editor:
We read with great interest the article by
Machtay and colleagues,1 which underlines
the feasibility of trimodality treatment
(concurrent chemoradiation followed by
surgical intervention) in the cure of locally
advanced non–small cell lung cancer (LA-
NSCLC) and suggest the use of pathologic
downstaging as a predictor for long-term
survival.
Several studies have explored the com-
bined trimodality treatment: in the ESSEN2
and SWOG3 trials, patients have been
treated with cisplatin plus etoposide (the
same drugs used in this study for 22 pa-
tients) with a similar radiation dose (45
Gy). They reported a rate of acute toxicity
similar to that reported in this article, with
esophageal toxicities as the most frequent.
Esophageal toxicity could correlate with
the adopted radiotherapy volumes, which
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